OS Therapies Inc SEC filings OSTX
OS Therapies Inc has 243 filings in SEC EDGAR's recent list, going back to Dec 5, 2019. Its latest annual report, Form ARS, was filed on Jul 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, unregistered share sale, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Oct 23, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 19, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Oct 5, 2026 | Sep 29, 2026 |
| S-8 | Employee stock plan registration | Sep 21, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 10, 2026 | Sep 10, 2026 |
| 424B7 | Prospectus supplement | Sep 10, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 9, 2026 | Sep 9, 2026 |
| D | Filing | Aug 25, 2026 | — |
| 8-K |
Current report
Material agreement
|
Aug 21, 2026 | Aug 21, 2026 |
| 424B5 | Prospectus supplement | Aug 21, 2026 | — |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 12, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 6, 2026 | Jul 31, 2026 |
| 424B5 | Prospectus supplement | Aug 6, 2026 | — |
| 8-K |
Current report
Agreement ended
|
Jul 29, 2026 | Jul 23, 2026 |
| ARS | Annual report to shareholders | Jul 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Jul 24, 2026 | — |
| DEF 14A | Proxy statement | Jul 24, 2026 | Sep 9, 2026 |
| D | Filing | Jul 16, 2026 | — |
| 8-K/A | Amended current report | Jul 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Officer or director change, Other events
|
Jul 2, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 18, 2026 | Mar 31, 2026 |
| NT 10-Q | Notification of late filing | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 30, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 2, 2026 | Mar 31, 2026 |
| 424B5 | Prospectus supplement | Apr 2, 2026 | — |
| 8-K |
Current report
Other events
|
Mar 31, 2026 | Mar 31, 2026 |
| 424B7 | Prospectus supplement | Mar 31, 2026 | — |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| D | Filing | Mar 6, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 6, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Other events
|
Feb 13, 2026 | Feb 10, 2026 |
| D | Filing | Jan 20, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 12, 2026 | Jan 10, 2026 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| S-8 | Employee stock plan registration | Oct 31, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Oct 21, 2025 | Oct 21, 2025 |
| DEFA14A | Additional proxy material | Oct 17, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 17, 2025 | Oct 14, 2025 |
| 8-K |
Current report
Other events
|
Sep 30, 2025 | Sep 30, 2025 |
| 424B7 | Prospectus supplement | Sep 30, 2025 | — |
| D | Filing | Sep 10, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 2, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Agreement ended, Other events
|
Aug 26, 2025 | Aug 25, 2025 |
| ARS | Annual report to shareholders | Aug 26, 2025 | Dec 31, 2024 |
| EFFECT | Filing | Aug 25, 2025 | — |
| DEFA14A | Additional proxy material | Aug 25, 2025 | — |
| DEF 14A | Proxy statement | Aug 25, 2025 | Oct 14, 2025 |
| 424B5 | Prospectus supplement | Aug 25, 2025 | — |
| 424B3 | Prospectus | Aug 25, 2025 | — |
| CORRESP | Letter to the SEC | Aug 21, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 19, 2025 | Aug 19, 2025 |
| 10-Q | Quarterly report | Aug 18, 2025 | Jun 30, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 15, 2025 | Aug 15, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 15, 2025 | Aug 15, 2025 |
| NT 10-Q | Notification of late filing | Aug 15, 2025 | Jun 30, 2025 |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| EFFECT | Filing | Aug 12, 2025 | — |
| S-3 | Shelf registration | Aug 8, 2025 | — |
| CORRESP | Letter to the SEC | Aug 8, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2025 | — |
| S-1 | Registration statement | Aug 4, 2025 | — |
| D | Filing | Jul 16, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 14, 2025 | Jul 11, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 27, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 24, 2025 | Jun 23, 2025 |
| EFFECT | Filing | Jun 6, 2025 | — |
| CORRESP | Letter to the SEC | Jun 2, 2025 | — |
| UPLOAD | Letter from the SEC | May 28, 2025 | — |
| S-1 | Registration statement | May 23, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 16, 2025 | May 16, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| EFFECT | Filing | Apr 23, 2025 | — |
| EFFECT | Filing | Apr 23, 2025 | — |
| POS AM | Post-effective amendment | Apr 21, 2025 | — |
| POS AM | Registration statement | Apr 21, 2025 | — |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Other events
|
Apr 15, 2025 | Apr 9, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 9, 2025 | Apr 9, 2025 |
| DEFA14A | Additional proxy material | Apr 2, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 2, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| UPLOAD | Letter from the SEC | Mar 10, 2025 | — |
| DEF 14A | Proxy statement | Feb 28, 2025 | Mar 31, 2025 |
| EFFECT | Filing | Feb 13, 2025 | — |
| PRE 14A | Preliminary proxy statement | Feb 7, 2025 | Feb 7, 2025 |
| CORRESP | Letter to the SEC | Feb 7, 2025 | — |
| CORRESP | Letter to the SEC | Feb 5, 2025 | — |
| CORRESP | Letter to the SEC | Feb 4, 2025 | — |
| CORRESP | Letter to the SEC | Feb 4, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 4, 2025 | — |
| CORRESP | Letter to the SEC | Jan 31, 2025 | — |
| S-1 | Registration statement | Jan 31, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Jan 29, 2025 | Jan 28, 2025 |
| D | Filing | Jan 22, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 15, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 14, 2025 | Jan 10, 2025 |
| EFFECT | Filing | Jan 13, 2025 | — |
| S-8 | Employee stock plan registration | Jan 13, 2025 | — |
| CORRESP | Letter to the SEC | Jan 10, 2025 | — |
| CORRESP | Letter to the SEC | Jan 3, 2025 | — |
| S-1/A | Amended registration statement | Jan 3, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Dec 30, 2024 | Dec 24, 2024 |
| S-1/A | Amended registration statement | Nov 27, 2024 | — |
| CORRESP | Letter to the SEC | Nov 27, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 15, 2024 | Nov 15, 2024 |
| 10-Q | Quarterly report | Nov 15, 2024 | Sep 30, 2024 |
| NT 10-Q | Notification of late filing | Nov 14, 2024 | Sep 30, 2024 |
| S-1 | Registration statement | Nov 12, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 1, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 28, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Other events
|
Aug 22, 2024 | Aug 22, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2024 | Aug 15, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 424B4 | Prospectus | Aug 1, 2024 | — |
| EFFECT | Filing | Jul 31, 2024 | — |
| CERT | Nyse american certification | Jul 30, 2024 | — |
| 8-A12B | For registration of certain classes | Jul 30, 2024 | — |
| CORRESP | Letter to the SEC | Jul 26, 2024 | — |
| CORRESP | Letter to the SEC | Jul 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 20, 2024 | — |
| CORRESP | Letter to the SEC | Jun 20, 2024 | — |
| CORRESP | Letter to the SEC | Jun 18, 2024 | — |
| CORRESP | Letter to the SEC | Jun 18, 2024 | — |
| CORRESP | Letter to the SEC | Jun 13, 2024 | — |
| S-1/A | Amended registration statement | Jun 13, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2024 | — |
| CORRESP | Letter to the SEC | Jun 7, 2024 | — |
| S-1/A | Amended registration statement | Jun 7, 2024 | — |
| RW | Filing | Jun 3, 2024 | — |
| RW | Filing | Jun 3, 2024 | — |
| S-1 | Registration statement | May 30, 2024 | — |
| RW | Withdrawal request | May 30, 2024 | — |
| 10-Q | Quarterly report | May 20, 2024 | Mar 31, 2024 |
| SP 15D2 | Special financial report | May 20, 2024 | Dec 31, 2023 |
| NT 10-Q | Notification of late filing | May 15, 2024 | Mar 31, 2024 |
| NT 10-K | Notification of late filing | May 15, 2024 | Dec 31, 2023 |
| POS AM | Post-effective amendment | May 13, 2024 | — |
| SEC STAFF LETTER | Filing | Feb 14, 2024 | — |
| EFFECT | Filing | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 12, 2024 | — |
| CORRESP | Letter to the SEC | Feb 12, 2024 | — |
| S-1/A | Amended registration statement | Jan 25, 2024 | — |
| CORRESP | Letter to the SEC | Jan 24, 2024 | — |
| CORRESP | Letter to the SEC | Dec 22, 2023 | — |
| S-1/A | Amended registration statement | Dec 22, 2023 | — |
| D | Filing | Dec 14, 2023 | — |
| CORRESP | Letter to the SEC | May 22, 2023 | — |
| S-1/A | Amended registration statement | May 22, 2023 | — |
| CORRESP | Letter to the SEC | Apr 24, 2023 | — |
| S-1/A | Amended registration statement | Apr 24, 2023 | — |
| CORRESP | Letter to the SEC | Apr 13, 2023 | — |
| S-1/A | Amended registration statement | Apr 13, 2023 | — |
| SEC STAFF LETTER | Filing | Apr 10, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2023 | — |
| CORRESP | Letter to the SEC | Mar 31, 2023 | — |
| S-1 | Registration statement | Mar 31, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2023 | — |
| DRS/A | Filing | Mar 14, 2023 | — |
| DRSLTR | Filing | Mar 13, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 20, 2023 | — |
| DRSLTR | Filing | Jan 20, 2023 | — |
| DRS/A | Filing | Jan 20, 2023 | — |
| D | Filing | Jan 11, 2023 | — |
| DRS | Filing | Nov 23, 2022 | — |
| D | Filing | Sep 1, 2021 | — |
| D | Filing | May 1, 2020 | — |
| D | Filing | Dec 5, 2019 | — |
Showing 174 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OSTX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rockville, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1795091
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.